Trevi Therapeutics (TRVI) Soars as Haduvio Taps Into $15B Addressable Market
Trevi Therapeutics grew its share prices by 9.85 percent on Friday to finish at $19.07 apiece, after management underscored strong clinical trial results from its treatment candidate for chronic cough...





